Results 171 to 180 of about 747,119 (356)

Increased packed cell volume alters point of care viscoelastic clotting parameters in horses

Equine Veterinary Journal, Volume 57, Issue 3, Page 766-773, May 2025.
Abstract Background Polycythaemia and coagulopathy are identified risk factors for non‐survival in critically ill horses. Assessment of coagulation is recommended for critical care monitoring but may be affected by concurrent polycythaemia. Objective To evaluate the effects of induced polycythaemia on coagulation parameters as measured by a point‐of ...
Rebecca C. Bishop, Kaitlyn M. Jonk, Alessandro Migliorisi, Scott M. Austin, Emma C. Mullins, Pamela A. Wilkins   +5 more
wiley   +1 more source

Variation in coagulation factor activity levels cause discrepancies between activated partial thromboplastin time and anti-Xa activity for heparin monitoring: a retrospective observational study. [PDF]

J Intensive Care, 2023
Saito T, Hayakawa M, Kumano O, Honma Y, Murashita M, Kato J, Fukui S, Takahashi M, Takahashi Y, Tsuchida T, Mizugaki A, Takauji S, Hayamizu M, Yoshida T, Katabami K, Wada T, Maekawa K.   +16 more
europepmc   +1 more source

Integration of machine learning and viscoelastic testing to improve survival prediction in horses experiencing acute abdominal pain at a veterinary teaching hospital

Equine Veterinary Journal, EarlyView.
Abstract Background Viscoelastic coagulation testing (VCT) identifies subclinical disruption of coagulation homeostasis and may improve prognostication, particularly for patients with severe systemic inflammation or shock. Machine learning (ML) algorithms may capture complex relationships between clinical variables better than linear regression (GLM ...
Brandi M. Macleod, Pamela A. Wilkins, Annette M. McCoy, Rebecca C. Bishop   +3 more
wiley   +1 more source

Activated Partial Thromboplastin Time and Mortality in Coronary Artery Bypass Grafting Patients. [PDF]

Dis Markers, 2022
Zhang H, Tian W, Qi G, Sun L, Wei X.
europepmc   +1 more source

Prognostic value of prothrombin time and activated partial thromboplastin time in patients with posttraumatic disseminated intravascular coagulation.

, 1994
Satoshi Gando, Satoshi Nanzaki, Takashi Kameue, Hiroshi Makise, Yoshimi Nakanishi   +4 more
openalex   +2 more sources

Biphasic Activated Partial Thromboplastin Time Waveform and Adverse Events in Non-Intensive Care Unit Patients [PDF]

, 2004
Eve Y. Smith, Linda Charles, Elizabeth M. Van Cott   +2 more
openalex   +1 more source

A 5-Month-Old Male With an Isolated Prolonged Partial Thromboplastin Time [PDF]

, 2007
Alde Carlo P. Gavino
openalex   +2 more sources

Acquired coagulopathy owing to parenteral cefamandole: renal failure as a predisposing factor. [PDF]

, 1983
Within a span of four months at a 550 bed community hospital, four elderly patients who had been taking cefamandole for various infections developed a severe coagulopathy within 10 days after initiation of cefamandole.
Chang, Jae C
core  

Wound, pressure ulcer, and burn guidelines (2023)―4: Guidelines for the management of connective tissue disease/vasculitis‐associated skin ulcers, third edition

The Journal of Dermatology, EarlyView.
Yoshihide Asano, Jun Asai, Takayuki Ishii, Yohei Iwata, Masanari Kodera, Chie Miyabe, Akihiko Uchiyama, Youichi Ogawa, Ken Okamura, Mari Kishibe, Yuta Koike, Yorihisa Kotobuki, Noriki Fujimoto, Takuya Miyagi, Yukie Yamaguchi, Ayumi Yoshizaki, Reiko Omori, Takeshi Nakanishi, Hiroshi Fujiwara, Takeo Maekawa, Sei‐ichiro Motegi, Yuichiro Yoshino, Minoru Hasegawa, Manabu Fujimoto, Takao Tachibana, Wound, Pressure Ulcer, and Burn Guidelines Drafting Committee (connective tissue disease/vasculitis group)   +27 more
wiley   +1 more source

Factor VIII Activity and Factor VIII Inhibitors Can Be Measured Accurately in Plasma Containing Mim8 by Using Specific Chromogenic Assays

Haemophilia, Volume 31, Issue 2, Page 319-327, March 2025.
ABSTRACT Introduction Patients with Haemophilia A treated with Mim8 may require concomitant Factor VIII (FVIII) replacement; hence, accurate assessment of FVIII activity (FVIII:C) and FVIII inhibitors in the presence of Mim8 is important. Aim Assess which chromogenic substrate assays (CSAs) accurately monitor FVIII:C and FVIII inhibitor levels in the ...
William Pickering, Mary Robinson, Caroline Cogswell, Wan Hui Ong Clausen, Karin Nana Weldingh, Mirella Ezban   +5 more
wiley   +1 more source